• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

韩国炎症性肠病患者的结直肠癌风险:一项关于亚型和社会经济差异的全国性大数据研究

Colorectal Cancer Risk in Korean Patients with Inflammatory Bowel Disease: A Nationwide Big Data Study of Subtype and Socioeconomic Disparities.

作者信息

Han Kyeong Min, Kang Ho Suk, Kim Joo-Hee, Choi Hyo Geun, Yoo Dae Myoung, Kim Nan Young, Park Ha Young, Kwon Mi Jung

机构信息

Hallym Data Science Laboratory, Hallym University College of Medicine, Anyang 14068, Republic of Korea.

Division of Gastroenterology, Department of Internal Medicine, Hallym University Sacred Heart Hospital, Hallym University College of Medicine, Anyang 14068, Republic of Korea.

出版信息

J Clin Med. 2025 Aug 5;14(15):5503. doi: 10.3390/jcm14155503.

DOI:10.3390/jcm14155503
PMID:40807124
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12347564/
Abstract

: The two major subtypes of inflammatory bowel disease (IBD)-Crohn's disease (CD) and ulcerative colitis (UC)-are known to increase the likelihood of developing colorectal cancer (CRC). While this relationship has been well studied in Western populations, evidence from East Asia remains limited and inconsistent. Using nationwide cohort data, this study explored the potential connection between IBD and CRC in a large Korean population. : We conducted a retrospective cohort study using data from the Korean National Health Insurance Service-National Sample Cohort from 2005 to 2019. A total of 9920 CRC patients were matched 1:4 with 39,680 controls using propensity scores based on age, sex, income, and region. Overlap weighting and multivariable logistic regression were used to evaluate the association between IBD and CRC. Subgroup analyses were conducted to assess effect modification by demographic and clinical factors. : IBD markedly increased the likelihood of developing CRC (adjusted odds ratio (aOR) = 1.38; 95% confidence interval (CI): 1.20-1.58; < 0.001), with the association primarily driven by UC (aOR = 1.52; 95% CI: 1.27-1.83). CD appeared unrelated to heightened CRC risk overall, though a significant association was observed among low-income CD patients (aOR = 1.58; 95% CI: 1.15-2.16). The UC-CRC association persisted across all subgroups, including patients without comorbidities. : Our findings support an independent association between IBD-particularly UC-and increased CRC risk in Korea. These results underscore the need for personalized CRC surveillance strategies that account for disease subtype, comorbidity burden, and socioeconomic status, especially in vulnerable subpopulations.

摘要

炎症性肠病(IBD)的两种主要亚型——克罗恩病(CD)和溃疡性结肠炎(UC)——已知会增加患结直肠癌(CRC)的可能性。虽然这种关系在西方人群中已有充分研究,但来自东亚的证据仍然有限且不一致。本研究利用全国队列数据,探讨了在大量韩国人群中IBD与CRC之间的潜在联系。

我们使用了韩国国民健康保险服务全国样本队列2005年至2019年的数据进行了一项回顾性队列研究。根据年龄、性别、收入和地区的倾向得分,共9920例CRC患者与39680例对照进行了1:4匹配。采用重叠加权和多变量逻辑回归来评估IBD与CRC之间的关联。进行亚组分析以评估人口统计学和临床因素的效应修正。

IBD显著增加了患CRC的可能性(调整后的优势比(aOR)=1.38;95%置信区间(CI):1.20-1.58;P<0.001),这种关联主要由UC驱动(aOR = 1.52;95%CI:1.27-1.83)。总体而言,CD似乎与CRC风险升高无关,不过在低收入CD患者中观察到显著关联(aOR = 1.58;95%CI:1.15-2.16)。UC与CRC的关联在所有亚组中均持续存在,包括无合并症的患者。

我们的研究结果支持在韩国IBD(尤其是UC)与CRC风险增加之间存在独立关联。这些结果强调了需要制定个性化的CRC监测策略,该策略要考虑疾病亚型、合并症负担和社会经济地位,特别是在弱势群体中。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2dcc/12347564/e27aded953ca/jcm-14-05503-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2dcc/12347564/d05789b347ed/jcm-14-05503-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2dcc/12347564/1aa2af724a85/jcm-14-05503-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2dcc/12347564/0a8b9810bb69/jcm-14-05503-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2dcc/12347564/e27aded953ca/jcm-14-05503-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2dcc/12347564/d05789b347ed/jcm-14-05503-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2dcc/12347564/1aa2af724a85/jcm-14-05503-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2dcc/12347564/0a8b9810bb69/jcm-14-05503-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2dcc/12347564/e27aded953ca/jcm-14-05503-g004.jpg

相似文献

1
Colorectal Cancer Risk in Korean Patients with Inflammatory Bowel Disease: A Nationwide Big Data Study of Subtype and Socioeconomic Disparities.韩国炎症性肠病患者的结直肠癌风险:一项关于亚型和社会经济差异的全国性大数据研究
J Clin Med. 2025 Aug 5;14(15):5503. doi: 10.3390/jcm14155503.
2
Strategies for detecting colon cancer in patients with inflammatory bowel disease.炎症性肠病患者结肠癌的检测策略。
Cochrane Database Syst Rev. 2017 Sep 18;9(9):CD000279. doi: 10.1002/14651858.CD000279.pub4.
3
Impact of moderate-to-severe ulcerative colitis and Crohn's disease on sexual activity: United States and European patient perspectives from the communicating needs and features of IBD experiences (CONFIDE) survey.中重度溃疡性结肠炎和克罗恩病对性活动的影响:来自炎症性肠病经历的沟通需求与特征(CONFIDE)调查的美国和欧洲患者观点
Curr Med Res Opin. 2025 Jul 17:1-14. doi: 10.1080/03007995.2025.2530736.
4
Interventions for the management of abdominal pain in Crohn's disease and inflammatory bowel disease.干预措施用于克罗恩病和炎症性肠病的腹痛管理。
Cochrane Database Syst Rev. 2021 Nov 29;11(11):CD013531. doi: 10.1002/14651858.CD013531.pub2.
5
Ischemic Stroke May Increase the Risk of Crohn's Disease and Ulcerative Colitis: Evidence from a Bidirectional Mendelian Randomization Study.缺血性中风可能增加克罗恩病和溃疡性结肠炎的风险:来自双向孟德尔随机化研究的证据。
World Neurosurg. 2025 Apr;196:123718. doi: 10.1016/j.wneu.2025.123718. Epub 2025 Mar 13.
6
Strategies for detecting colon cancer and/or dysplasia in patients with inflammatory bowel disease.检测炎症性肠病患者结肠癌和/或发育异常的策略。
Cochrane Database Syst Rev. 2006 Apr 19(2):CD000279. doi: 10.1002/14651858.CD000279.pub3.
7
Tolerability of selective cyclooxygenase 2 inhibitors used for the treatment of rheumatological manifestations of inflammatory bowel disease.用于治疗炎症性肠病风湿性表现的选择性环氧化酶2抑制剂的耐受性
Cochrane Database Syst Rev. 2014 Oct 23;2014(10):CD007744. doi: 10.1002/14651858.CD007744.pub2.
8
Vitamin D for the treatment of inflammatory bowel disease.维生素 D 治疗炎症性肠病。
Cochrane Database Syst Rev. 2023 Oct 2;10(10):CD011806. doi: 10.1002/14651858.CD011806.pub2.
9
Healthcare resource utilization and production loss in vedolizumab-treated inflammatory bowel disease patients: results from the Swedish prospective multicentre SVEAH study.维多珠单抗治疗的炎症性肠病患者的医疗资源利用和生产损失:瑞典前瞻性多中心SVEAH研究的结果
Therap Adv Gastroenterol. 2025 Jul 17;18:17562848251352023. doi: 10.1177/17562848251352023. eCollection 2025.
10
Strategies for detecting colon cancer and/or dysplasia in patients with inflammatory bowel disease.检测炎症性肠病患者结肠癌和/或发育异常的策略。
Cochrane Database Syst Rev. 2004(2):CD000279. doi: 10.1002/14651858.CD000279.pub2.

本文引用的文献

1
Ulcerative colitis-associated colorectal neoplasm is increasing as a surgical indication in the biologics era: a retrospective observational study of 20 years of experience in a single tertiary center.在生物制剂时代,溃疡性结肠炎相关结直肠肿瘤作为一种手术指征正在增加:一项对单一三级中心20年经验的回顾性观察研究。
Ann Surg Treat Res. 2025 Mar;108(3):150-157. doi: 10.4174/astr.2025.108.3.150. Epub 2025 Feb 28.
2
Inflammatory Bowel Disease and Colorectal Cancer: Epidemiology, Etiology, Surveillance, and Management.炎症性肠病与结直肠癌:流行病学、病因学、监测与管理
Cancers (Basel). 2023 Aug 17;15(16):4154. doi: 10.3390/cancers15164154.
3
Colorectal cancer among inflammatory bowel disease patients: risk factors and prevalence compared to the general population.
炎症性肠病患者中的结直肠癌:与普通人群相比的风险因素和患病率
Front Med (Lausanne). 2023 Aug 7;10:1225616. doi: 10.3389/fmed.2023.1225616. eCollection 2023.
4
Global burden of colorectal cancer in 2020 and 2040: incidence and mortality estimates from GLOBOCAN.2020年和2040年全球结直肠癌负担:来自全球癌症负担(GLOBOCAN)的发病率和死亡率估计
Gut. 2023 Feb;72(2):338-344. doi: 10.1136/gutjnl-2022-327736. Epub 2022 Sep 8.
5
Association of the inflammatory balance of diet and lifestyle with colorectal cancer among Korean adults: a case-control study.饮食和生活方式的炎症平衡与韩国成年人结直肠癌的关联:病例对照研究。
Epidemiol Health. 2022;44:e2022084. doi: 10.4178/epih.e2022084. Epub 2022 Sep 30.
6
Inflammatory bowel disease in Korea: epidemiology and pathophysiology.韩国的炎症性肠病:流行病学和病理生理学。
Korean J Intern Med. 2022 Sep;37(5):885-894. doi: 10.3904/kjim.2022.138. Epub 2022 Jul 29.
7
Incidence and Prevalence of Inflammatory Bowel Disease across Asia.亚洲炎症性肠病的发病率和患病率。
Yonsei Med J. 2021 Feb;62(2):99-108. doi: 10.3349/ymj.2021.62.2.99.
8
Time trends of colorectal cancer incidence and associated lifestyle factors in South Korea.韩国结直肠癌发病率的时间趋势及相关生活方式因素。
Sci Rep. 2021 Jan 28;11(1):2413. doi: 10.1038/s41598-021-81877-2.
9
Overlap Weighting: A Propensity Score Method That Mimics Attributes of a Randomized Clinical Trial.重叠加权法:一种模拟随机临床试验属性的倾向评分方法。
JAMA. 2020 Jun 16;323(23):2417-2418. doi: 10.1001/jama.2020.7819.
10
A 30-year Trend Analysis in the Epidemiology of Inflammatory Bowel Disease in the Songpa-Kangdong District of Seoul, Korea in 1986-2015.1986-2015 年韩国首尔松坡-姜洞地区炎症性肠病的 30 年流行病学趋势分析。
J Crohns Colitis. 2019 Oct 28;13(11):1410-1417. doi: 10.1093/ecco-jcc/jjz081.